First podocyte toxicity assay now commercially available
in vitro testing of glomerular toxicity of drugs and toxins is now available using a validated podocyte model developed by Newcells’ kidney experts.
Why work with Newcells?
We have high scientific standards: all our models are fully characterised and undergo rigorous validations giving us full confidence in the data we generate for our clients.
Our podocyte model is composed of a monolayer of freshly isolated and fully differentiated podocytes. The podocyte model recapitulates the structure and function of the glomerular filtration barrier showing size and charge selectivity which can be modulated by the addition of know nephrotoxic drugs affecting the GFB such as puromycin and adriamycin.
Well-established supplier with leading experts
Our glomerulus team leader and head of kidney development, Dr Kathryn Garner, is an expert in podocytes and was the recipient of a Kidney Research UK fellowship. She has a deep understanding of podocyte biology and physiology.
Dr Garner is already working on a more complex multi-cellular glomerulus model containing podocytes, endothelial cells and mesangial cells.
Fully customised and timely service
We work closely with our customers to define a tailored study design that best delivers the required data outputs. With a regular supply of tissue, our study protocols are rapidly completed by our experienced team to provide robust data to help our clients make key decisions during drug discovery.
More about the science behind the model:
- Poster presentation at MPS World Summit 2022: in vitro model of podocyte damage.
- A webinar on developing high content imaging for chronic kidney disease
Want to speak to one of our experts about this product?
Please contact us to arrange a call.Contact us
Share on social media:
Don't miss out on our latest innovations: follow us on Linkedin
12th October, 2022